Loading…

Binuclear meta-xylyl-linked Ag(I)-N-heterocyclic carbene complexes of N-alkyl/aryl-alkyl-substituted bis-benzimidazolium salts: synthesis, crystal structures and in vitro anticancer studies

Salts of meta‐xylyl‐linked N‐ethyl/n‐butyl/benzyl‐substituted bis‐benzimidazolium having hexafluorophosphate counterions have been synthesized. The corresponding binuclear Ag(I)‐N‐heterocyclic carbene complexes were prepared by the reaction of Ag2O. The N‐heterocyclic carbene (NHC) ligand precursor...

Full description

Saved in:
Bibliographic Details
Published in:Applied organometallic chemistry 2013-04, Vol.27 (4), p.214-223
Main Authors: Haque, Rosenani A., Iqbal, Muhammad Adnan, Budagumpi, Srinivasa, Khadeer Ahamed, Mohamed B., Abdul Majid, Amin M. S., Hasanudin, Noorhafizah
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Salts of meta‐xylyl‐linked N‐ethyl/n‐butyl/benzyl‐substituted bis‐benzimidazolium having hexafluorophosphate counterions have been synthesized. The corresponding binuclear Ag(I)‐N‐heterocyclic carbene complexes were prepared by the reaction of Ag2O. The N‐heterocyclic carbene (NHC) ligand precursor 7 and Ag(I)–NHC complexes 10 and 11 have been structurally characterized by single‐crystal X‐ray diffraction technique. All of the reported compounds have been tested for their anticancer activity using human colorectal (HCT 116) cancer cell lines. Sterically varied benzimidazolium salts displayed significant activity against HCT 116 cell line, yielding IC50 values in the range 0.1–19.4 µ m, while Ag(I)–carbene complexes showed exceptionally good activity (0.2–1.3 µ m) against tested cancer cell lines. Copyright © 2013 John Wiley & Sons, Ltd. Meta‐xylyl‐bridged symmetrically substituted Ag(I)‐N‐heterocyclic carbene complexes were prepared and have been tested for their anticancer activity using human colorectal (HCT 116) cancer cell lines. Ag(I)‐carbene complexes showed exceptionally good activity (0.2‐1.3 µM) against tested cancer cell lines.
ISSN:0268-2605
1099-0739
DOI:10.1002/aoc.2953